---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-218522"
form_type: "8-K"
ticker: "RMD"
cik: "0000943819"
company_name: "RESMED INC"
filed_at: "2022-08-11T23:59:59+00:00"
generated_at: "2026-06-24T01:16:37.728754+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ResMed Q4 revenue $914.7M (+4% YoY); dividend up 5% to $0.44; acquires MEDIFOX DAN for $1B

## Summary
- Q4 revenue $914.7M (+4% YoY, +8% constant currency); GAAP diluted EPS $1.33.
- Full-year revenue $3.58B (+12% YoY, +13% constant currency); GAAP EPS $5.30.
- Quarterly dividend raised 5% to $0.44/share, payable Sept 22, record Aug 18.
- Announced $1B acquisition of MEDIFOX DAN, a German out-of-hospital software company; expected close by Dec 31, 2022.
- Lucile Blaise promoted to President of Sleep & Respiratory Care effective July 1, 2022.

## SEC filing metadata
- accession: 0001193125-22-218522
- form_type: 8-K
- ticker: RMD
- cik: 0000943819
- company_name: RESMED INC
- filed_at: 2022-08-11T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/943819/000119312522218522/0001193125-22-218522-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/943819/000119312522218522/d392713d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-218522
- JSON: https://secwatch.observer/filing/0001193125-22-218522.json
- Plain text: https://secwatch.observer/filing/0001193125-22-218522.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.